An iterative method to protect the type I error rate in bioequivalence studies under two‐stage adaptive 2×2 crossover designs
From MaRDI portal
Publication:6067315
DOI10.1002/BIMJ.201900388zbMath1523.62169OpenAlexW3091202292WikidataQ100404411 ScholiaQ100404411MaRDI QIDQ6067315
Unnamed Author, Unnamed Author, Unnamed Author, Jordi Ocanã, Helmut Schütz
Publication date: 16 November 2023
Published in: Biometrical Journal (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1002/bimj.201900388
average bioequivalence (ABE)generic drug productsignificance level adjustmenttwo-stage adaptive designs (TSD)type I error control (T1E)
This page was built for publication: An iterative method to protect the type I error rate in bioequivalence studies under two‐stage adaptive 2×2 crossover designs